Sales & Marketing Changing Faces – Pharma and biotech hires – August and Septe... It’s been a busy couple of months in the world of pharma hires as Merck KGaA and GSK both made some big changes at the top.
News After FDA exit, Peter Marks pops up at Lilly The ousted former director of CBER, Peter Marks, has joined Eli Lilly as head of molecular discovery and infectious disease research.
News Walmsley to leave GSK in surprise exit This week has kicked off with the news that Emma Walmsley is standing down as chief executive of GSK after eight years, to be replaced by Luke Miels.
News Merck names electronics unit head to replace Garijo as CEO Merck KGaA's CEO Belén Garijo will step down next year and will be replaced by the group's electronics boss Kai Beckmann.
News Merck names new R&D chief for healthcare business Industry veteran David Weinreich will step into the top healthcare R&D role at Merck KGaA, following Danny Bar-Zohar's move to lead the division.
Sales & Marketing Changing Faces – Board of Director and Advisory Board hires ... This month’s boardroom activity across biotech, diagnostics, CROs, and digital health companies highlights a strategic push for scientific excellence, commercial acumen, and global leadersh
Patients Biosimilars & patient access independent of geographies or s... Rebecca Guntern, Sandoz' CCO, discusses the ‘golden decade’ for generics and biosimilars as so many blockbuster drugs come off patent.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.